In our recent studies, we reported downregulated expression of FXR in both IBD patients and dextran sodium sulfate (DSS)-induced IBD mice model, which was accompanied by altered primary bile acid biosynthesis. The gene discussed is NR1H4; the disease is inflammatory bowel disease.